# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-21-207605
Filing Date
2021-07-02
Accepted
2021-07-02 16:09:41
Documents
19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B4 | d104413d424b4.htm | 424B4 | 1925787
2 | GRAPHIC | g104413g00q15.jpg | GRAPHIC | 177155
3 | GRAPHIC | g104413g03a03.jpg | GRAPHIC | 147367
4 | GRAPHIC | g104413g04q02.jpg | GRAPHIC | 138433
5 | GRAPHIC | g104413g11t00.jpg | GRAPHIC | 138632
6 | GRAPHIC | g104413g20a69.jpg | GRAPHIC | 81786
7 | GRAPHIC | g104413g21g20.jpg | GRAPHIC | 45080
8 | GRAPHIC | g104413g22y47.jpg | GRAPHIC | 64941
9 | GRAPHIC | g104413g30s55.jpg | GRAPHIC | 51058
10 | GRAPHIC | g104413g51i08.jpg | GRAPHIC | 106470
11 | GRAPHIC | g104413g52c34.jpg | GRAPHIC | 48150
12 | GRAPHIC | g104413g56t67.jpg | GRAPHIC | 84325
13 | GRAPHIC | g104413g64m48.jpg | GRAPHIC | 90608
14 | GRAPHIC | g104413g71z61.jpg | GRAPHIC | 52889
15 | GRAPHIC | g104413g82e41.jpg | GRAPHIC | 64605
16 | GRAPHIC | g104413g89k52.jpg | GRAPHIC | 88136
17 | GRAPHIC | g104413g89w33.jpg | GRAPHIC | 87529
18 | GRAPHIC | g104413g92p79.jpg | GRAPHIC | 201333
19 | GRAPHIC | g104413g98x03.jpg | GRAPHIC | 85803
| Complete submission text file | 0001193125-21-207605.txt |  | 4332459

Mailing Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551
Business Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-256945 | Film No.: 211070077
SIC: 2836 Biological Products, (No Diagnostic Substances)